SC
NUVB icon

Shay Capital’s Nuvation Bio NUVB Stock Holding History

Shay Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937K Sell
165,000
-10,056
-6% -$49.1K 0.06% 220
2026
Q1 		$751K Buy
+175,056
New +$975K 0.06% 209
2024
Q1 		– Sell
-124,607
Closed -$188K – 450
2023
Q4 		$188K Buy
+124,607
New +$160K 0.04% 206

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Shay Capital's NUVB Position: Q2 2026 in Review

Shay Capital reduced its Nuvation Bio (NUVB) stake by 5.7% in Q2 2026, selling an estimated $49.1K and leaving 165,000 shares worth $937K. The position accounts for 0.06% of the portfolio, ranked #220.

Shay Capital first reported a position in NUVB in Q4 2023 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Shay Capital held 165,000 shares of Nuvation Bio worth $937K as of Q2 2026.
  • Shay Capital sold 10,056 Nuvation Bio shares in Q2 2026, an estimated $49.1K.
  • Nuvation Bio made up 0.06% of Shay Capital's portfolio in Q2 2026, its #220 holding.
  • Shay Capital first reported a position in Nuvation Bio in Q4 2023 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.